NCT02254070View on ClinicalTrials.gov

Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2004

Conditions
Healthy
Interventions
DRUG

BIBT 986 BS

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY